| Record ID | marc_loc_2016/BooksAll.2016.part18.utf8:180702967:990 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_2016/BooksAll.2016.part18.utf8:180702967:990?format=raw |
LEADER: 00990cam a2200313 a 4500
001 88042830
003 DLC
005 19930804143936.1
008 880606s1989 nyua b 00110 eng c
010 $a 88042830 //r93
020 $a088167463X
040 $aDNLM/DLC$cDLC$dDLC
050 00 $aHD9665.5$b.S68 1989
060 $aQV 736 S756m
082 00 $a338.8/8716151$220
100 10 $aSpilker, Bert.
245 10 $aMultinational drug companies :$bissues in drug discovery and development /$cBert Spilker.
260 0 $aNew York :$bRaven Press,$cc1989.
300 $axxvi, 606 p. :$bill. ;$c26 cm.
504 $aBibliography: p. 569-582.
500 $aIncludes index.
650 0 $aPharmaceutical industry.
650 0 $aPharmaceutical industry$xTechnological innovations.
650 0 $aDrugs$xResearch$xManagement.
650 0 $aInternational business enterprises.
650 2 $aDrug Industry.
650 2 $aDrug Screening.
650 2 $aResearch.
650 2 $aTechnology, Pharmaceutical.